Transdermal bioidentical estradiol may carry a lower risk of clotting than oral forms because it avoids first-pass liver

https://www.reverbnation.com/artist/percantraq

Transdermal bioidentical estradiol may carry a lower risk of clotting than oral forms because it avoids first-pass liver metabolism, potentially making it preferable for some high-risk patients.